33 results
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
8 Jan 24
Results of Operations and Financial Condition
6:55am
AAT aggregates in liver causing damage Lack of AAT secretionleads to lung damage American Thoracic Society/European Respiratory Society statement
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
8 Nov 23
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
7:00am
in vivo, with results lasting more than one year, in an oral presentation at the 30th Annual European Society of Gene & Cell Therapy (ESGCT) Congress
8-K
EX-99.1
kb7c9gj4x 0xnbj
10 May 23
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
7:00am
8-K
EX-99.1
ymhcmxtegjy8bi
7 Nov 22
Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
vbgq4ndx
9 Aug 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
mrdkfg2e
9 May 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports First Quarter 2022 Financial Results
7:01am
8-K
EX-99.1
mmt8gy6cedmlzu0b aa3
28 Feb 22
Beam Therapeutics Reports Pipeline and Business Highlights, Planned 2022 Milestones and Fourth Quarter and Full Year 2021 Financial Results
7:00am
8-K
EX-99.1
o0bnc 93dxetq
8 Nov 21
Beam Therapeutics Provides Business and Pipeline Updates and Reports Third Quarter 2021 Financial Results
6:19am
8-K
EX-99.1
v569hf 7l95jfn2
11 May 21
Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results
7:48am
DEF 14A
tjoeu19frqoo1n xp
23 Apr 21
Definitive proxy
4:05pm